Craig L. Duvall
-
Duvall named Fellow of the Biomedical Engineering Society
Craig Duvall, Cornelius Vanderbilt Professor of Engineering, has been elevated to the rank of Fellow of the Biomedical Engineering Society. Duvall and his research program focus on development of technologies for controlled drug release, tissue regeneration and therapeutics, and delivery of intracellular-acting biologic drugs such as siRNA and peptide therapeutics. Read MoreAug. 10, 2020
-
Vanderbilt biomedical engineer receives presidential award for advanced wound healing research
Craig Duvall, Cornelius Vanderbilt Professor of Engineering, has been elevated to the rank of Fellow of the Biomedical Engineering Society. Duvall and his research program focus on development of technologies for controlled drug release, tissue regeneration and therapeutics, and delivery of intracellular-acting biologic drugs such as siRNA and peptide therapeutics. Read MoreJan. 31, 2017
-
Duvall to receive 2015 Society for Biomaterials Young Investigator Award for regenerative medicine research
Craig Duvall, Cornelius Vanderbilt Professor of Engineering, has been elevated to the rank of Fellow of the Biomedical Engineering Society. Duvall and his research program focus on development of technologies for controlled drug release, tissue regeneration and therapeutics, and delivery of intracellular-acting biologic drugs such as siRNA and peptide therapeutics. Read MoreJan. 22, 2015
-
Duvall receives NSF Early Career award
Craig Duvall, Cornelius Vanderbilt Professor of Engineering, has been elevated to the rank of Fellow of the Biomedical Engineering Society. Duvall and his research program focus on development of technologies for controlled drug release, tissue regeneration and therapeutics, and delivery of intracellular-acting biologic drugs such as siRNA and peptide therapeutics. Read MoreAug. 28, 2014
-
School of Engineering recruits 7 new faculty members
Craig Duvall, Cornelius Vanderbilt Professor of Engineering, has been elevated to the rank of Fellow of the Biomedical Engineering Society. Duvall and his research program focus on development of technologies for controlled drug release, tissue regeneration and therapeutics, and delivery of intracellular-acting biologic drugs such as siRNA and peptide therapeutics. Read MoreSep. 1, 2009